Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | PFE | Common Stock | Sale | -$9.87K | -200 | -0.05% | $49.36 | 397K | May 11, 2022 | Direct | |
transaction | PFE | Common Stock | Sale | -$116K | -2.36K | -0.59% | $49.34 | 395K | May 11, 2022 | Direct | |
transaction | PFE | Common Stock | Sale | -$143K | -2.89K | -0.73% | $49.35 | 392K | May 11, 2022 | Direct | |
transaction | PFE | Common Stock | Sale | -$389K | -7.88K | -2.01% | $49.33 | 384K | May 11, 2022 | Direct | |
transaction | PFE | Common Stock | Sale | -$915K | -18.6K | -4.83% | $49.32 | 365K | May 11, 2022 | Direct | |
transaction | PFE | Common Stock | Sale | -$1.58M | -32K | -8.76% | $49.31 | 333K | May 11, 2022 | Direct | |
holding | PFE | Common Stock | 1.82K | May 11, 2022 | By Rule 16b-3 Plan |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | PFE | Phantom Stock Units SSP | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities | $750K | +15.2K | +124.19% | $49.45 | 27.4K | May 11, 2022 | Common Stock | 15.2K | Direct | F1, F2, F3 |
Id | Content |
---|---|
F1 | Each unit represents one phantom share of common stock. |
F2 | This transaction constitutes an intra-plan transfer into the Pfizer stock unit fund under the Pfizer Inc. Supplemental Savings Plan. |
F3 | These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. |